Professional Summary
Professional Overview
Clay Cohorn is an accomplished medical device executive with extensive experience in clinical affairs, research, and reimbursement. As the Vice President of Clinical Affairs at Osteal Therapeutics, he leverages his deep industry expertise to drive the company's clinical strategy and oversee the execution of critical research initiatives.
Experience Summary
Current Role
As the Vice President of Clinical Affairs at Osteal Therapeutics, Clay is responsible for leading the company's clinical research and regulatory activities. In this role, he has been instrumental in securing FDA approval for two of the company's flagship orthopedic products, resulting in a significant increase in market share and revenue growth.
Career Progression
Prior to joining Osteal Therapeutics, Clay held several senior-level positions in the medical device industry, including Director of Clinical Research at Abbott, where he successfully managed the company's vascular intervention trials, and Senior Manager of Clinical Trial Reimbursement at St. Jude Medical, where he played a key role in securing favorable coverage policies for the company's cardiac devices.
Earlier in his career, Clay gained valuable experience as a Clinical Studies Engineer and Manager of Clinical Studies at BIOTRONIK, where he contributed to the development and commercialization of innovative cardiovascular technologies. He also served as a Clinical Engineer at Cyberonics, where he played a crucial role in the company's epilepsy device research and development efforts.
Academic Background
Clay holds a Bachelor of Science degree in Biomedical Engineering from the University of Texas at Austin, where he graduated with honors. His technical expertise and academic achievements have been instrumental in shaping his successful career in the medical device industry.
Areas of Expertise
- Clinical trial design and management
- Regulatory affairs and FDA submissions
- Reimbursement strategy and policy development
- Cross-functional team leadership and collaboration
- Medical device research and development
- Orthopedic and cardiovascular product lifecycles
Professional Impact
Throughout his career, Clay has consistently demonstrated a commitment to innovation and patient-centric care. His contributions have led to the successful commercialization of several medical devices, improving patient outcomes and advancing the industry as a whole. As the Vice President of Clinical Affairs at Osteal Therapeutics, he continues to drive the company's growth and strategic vision, positioning it as a leader in the orthopedic device market.
Conclusion
With over 15 years of experience in the medical device industry, Clay Cohorn has established himself as a respected and influential leader. His deep technical expertise, combined with his strategic vision and collaborative approach, make him a valuable asset to Osteal Therapeutics and the broader healthcare community.
